Medicare Enrolled
Dr. Gene Zitser, M.D.
Neurology · Oakland Gardens, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zitser from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zitser?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zitser
Dr. Gene Zitser is a neurology specialist in Oakland Gardens, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zitser performed 1,209 Medicare services across 803 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zitser received a total of $32,987 from 79 pharmaceutical and/or device companies across 1072 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zitser is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 25% volume in NY
$32,987 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,209
Medicare services
Top 25% in NY for neurology
803
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~60 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
462 | $82 | $154 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
141 | $88 | $117 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
82 | $214 | $405 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $143 | $204 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
49 | $47 | $68 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
42 | $28 | $111 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
42 | $71 | $149 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
42 | $20 | $146 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
42 | $234 | $317 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
39 | $220 | $299 |
| Autonomic nervous system testing, heart rate response This test evaluates the function of the autonomic nervous system by measuring how your heart rate responds to breathing exercises and changes in body position. |
38 | $41 | $161 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
38 | $45 | $165 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $96 | $145 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
28 | $155 | $259 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $50 | $81 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
23 | $242 | $357 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
15 | $189 | $247 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
12 | $254 | $338 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$32,987
Total received (2018-2024)
Avg $4,712/year across 7 years
Top 14% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,072
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,339 (61.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,648 (38.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,566
2023
$3,174
2022
$3,150
2021
$3,568
2020
$3,600
2019
$3,215
2018
$13,714
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$500
Neurelis, Inc.
$395
Neurocrine Biosciences, Inc.
$347
Teva Pharmaceuticals USA, Inc.
$319
PFIZER INC.
$155
Eisai Inc.
$115
Medtronic, Inc.
$100
UCB, Inc.
$95
ACADIA Pharmaceuticals Inc
$95
Grifols USA, LLC
$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$77
ARGENX US, INC.
$55
Amneal Pharmaceuticals LLC
$46
Novartis Pharmaceuticals Corporation
$39
MDD US Operations, LLC
$25
TG Therapeutics, Inc.
$24
Celgene Corporation
$23
SCILEX PHARMACEUTICALS INC.
$23
Amgen Inc.
$22
Lundbeck LLC
$18
Valinor Pharma, LLC
$16
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$11,549
Teva Pharmaceuticals USA, Inc.
$2,390
UCB, Inc.
$2,222
Allergan, Inc.
$1,378
AbbVie Inc.
$1,095
Biogen, Inc.
$1,089
Neurocrine Biosciences, Inc.
$1,068
ABBVIE INC.
$828
GENZYME CORPORATION
$797
Neurelis, Inc.
$763
Eisai Inc.
$757
PFIZER INC.
$670
SK Life Science, Inc.
$554
US WorldMeds, LLC
$445
Adamas Pharmaceuticals, Inc.
$402
ACADIA Pharmaceuticals Inc
$396
Novartis Pharmaceuticals Corporation
$366
Collegium Pharmaceutical, Inc.
$317
Amgen Inc.
$303
Celgene Corporation
$298
Scilex Pharmaceuticals Inc.
$289
Lundbeck LLC
$288
Avanir Pharmaceuticals, Inc.
$282
Harmony Biosciences LLC
$265
Lilly USA, LLC
$253
EMD Serono, Inc.
$210
Grifols USA, LLC
$206
Bausch Health US, LLC
$203
Allergan Inc.
$200
Neos Therapeutics, LP
$186
AbbVie, Inc.
$181
EISAI INC.
$176
Biohaven Pharmaceuticals, Inc.
$169
Amneal Pharmaceuticals LLC
$161
SCILEX PHARMACEUTICALS INC.
$160
JAZZ PHARMACEUTICALS INC.
$159
Medtronic, Inc.
$157
Sunovion Pharmaceuticals Inc.
$143
Biohaven Pharmaceutical Holding Company Ltd.
$134
Corium, LLC
$118
Impax Laboratories, Inc.
$96
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$77
HARMONY BIOSCIENCES LLC
$74
Boston Scientific Corporation
$64
Medtronic USA, Inc.
$62
Acorda Therapeutics, Inc
$56
ARGENX US, INC.
$55
Jazz Pharmaceuticals Inc.
$53
Alexion Pharmaceuticals, Inc.
$47
ITI, Inc.
$46
Aprecia Pharmaceuticals, LLC
$44
Kowa Pharmaceuticals America, Inc.
$42
RedHill Biopharma Inc.
$40
MDD US Operations, LLC
$39
Avion Pharmaceuticals
$39
Daiichi Sankyo Inc.
$37
Arbor Pharmaceuticals, Inc.
$34
Assertio Therapeutics, Inc.
$33
Merck Sharp & Dohme Corporation
$33
AQUESTIVE THERAPEUTICS, INC.
$32
Sumitomo Pharma America, Inc.
$29
TG Therapeutics, Inc.
$24
TG THERAPEUTICS, INC.
$24
CSL Behring
$22
E.R. Squibb & Sons, L.L.C.
$22
GRT US Holding, Inc.
$20
Zyla Life Sciences, Inc.
$20
CATALYST PHARMACEUTICALS, INC.
$20
Zyla Life Sciences
$20
Shire North American Group Inc
$20
Horizon Therapeutics plc
$19
Egalet US Inc
$19
Upsher-Smith Laboratories LLC
$18
LivaNova USA, Inc.
$18
Valinor Pharma, LLC
$16
Otsuka America Pharmaceutical, Inc.
$14
Promius Pharma LLC
$14
Virtus Pharmaceuticals LLC
$12
Forte Bio-Pharma LLC
$11
Top 3 companies account for 49.0% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Adzenys XR-ODT · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CAMBIA · CAPLYTA · COMIRNATY · COPAXONE · Cenobamate · Cotempla XR-ODT · Dhivy · Duopa · EMGALITY · EPIDIOLEX · FIRDAPSE · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · General - Pain Management · Gocovri · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LYRICA · Leqembi · Levorphanol · MIGRANAL · MOVANTIK · MYOBLOC · Mavenclad · Morphabond ER · Movantik · NALOCET · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · QELBREE · QUILLICHEW ER · QULIPTA · Qutenza · RAYOS · REXULTI · REYVOW · RYTARY · Rebif · SPRIX · SUNOSI · SYMPAZAN · Seglentis · Spritam · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART HYTRULO · Vimpat · WELLBUTRIN · Wakix · XTAMPZA · XTAMPZAER · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,223
Per 100K population
52.5
County median income
$84,961
Nearest hospital
CREEDMOOR PSYCHIATRIC CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zitser is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with low-engagement industry engagement in the top 14% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zitser experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Zitser performed 462 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zitser receive payments from pharmaceutical companies?
Yes. Dr. Zitser received a total of $32,987 from 79 companies across 1,072 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zitser's costs compare to other neurologists in Oakland Gardens?
Dr. Zitser's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zitser) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Oakland Gardens
Browse neurologists in Oakland Gardens ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology